Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory
Contact Dermatitis · 2025
DOI: 10.1111/cod.14715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2025. Verfasst von Linas Griguola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Patch Tests, Dermatitis, Occupational, Dicyclohexylcarbodiimide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Dicyclohexylcarbodiimide (DCC) is known to cause occupational allergic contact dermatitis in biotechnology laboratory workers.
Objectives
This study aimed to assess the prevalence of DCC sensitization among workers of one biosynthesis laboratory and to determine the optimal DCC concentration for patch testing. Materials and methods 23 laboratory workers frequently exposed to DCC of whom 21 suffered from dermatitis and 11 controls were enrolled into the study. All participants underwent skin patch testing with different concentrations of DCC and other substances used in the work environment. Statistical analysis was conducted to compare results between active and control groups.
Results
Of the 23 workers tested, 56.5% showed positive reactions to DCC. All of them had dermatitis. Morpholine also elicited positive reactions in 26.1% of workers who were all sensitized to DCC. Dimethylformamide and chloroform yielded negative results.
Conclusion
Dicyclohexylcarbodiimide was a major cause of contact dermatitis in the active group indicating an outbreak of contact allergy to DCC in the company necessitating preventive measures. Both DCC 0.1% ac. and DCC 0.05% pet. should both be used for patch testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonology and Allergology Center, VUH Santaros Klinikos, Vilnius, Lithuania.
- Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
ORCID-Profile: Linas Griguola, Laura Malinauskiene
Zitieren
APA
Griguola, L., Cerniauskas, K., Malinauskiene, L., Linauskiene, K., Rudyte, J., & Chomiciene, A. (2025). Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. https://doi.org/10.1111/cod.14715
Vancouver
Griguola L, Cerniauskas K, Malinauskiene L, Linauskiene K, Rudyte J, Chomiciene A. Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory. Contact Dermatitis. 2025. doi:10.1111/cod.14715
BibTeX
@article{Griguola2025,
author = {Griguola, Linas and Cerniauskas, Kestutis and Malinauskiene, Laura and Linauskiene, Kotryna and Rudyte, Justina and Chomiciene, Anzelika},
title = {Outbreak of contact allergy to dicyclohexylcarbodiimide in a biotechnology laboratory},
journal = {Contact Dermatitis},
year = {2025},
doi = {10.1111/cod.14715}
}
EUVIMED